Fungal Phylum Microsporidia
Surface Membrane Barriers
Factors Affecting the Risk of Infection
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Oct 21, 2025

Author Spotlight: Oral Candida Diagnosis to Advance Clinical Treatment Regimen for pSS Patients
Published on: March 1, 2024
Xin Lyu1, Hui Zheng2, Xu Wang1,2
1Department of Oral Medicine, Peking University School and Hospital of Stomatology, National Center of Stomatology, National Clinical Research Center for Oral Diseases, National Engineering Laboratory for Digital and Material Technology of Stomatology, Beijing Key Laboratory of Digital Stomatology, Research Center of Engineering and Technology for Computerized Dentistry Ministry of Health, NMPA Key Laboratory for Dental Materials, Beijing, China.
The oral microbiome differs significantly in chronic erythematous candidiasis patients compared to healthy individuals. Specific bacteria like Rothia mucilaginosa and Streptococcus mitis were enriched, suggesting the oral microbiome as a therapeutic target.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: